Pharma Update July 4, 2024: Asthma Symptoms Could Intensify with Lower Temperatures, FDA Clears New Alzheimer’s Medication Ushering In Advanced Treatment Phase & Beyond. Frank Dolan July 4, 2024
FDA Greenlights Kisunla by Lilly for Early Symptomatic Alzheimer’s Disease Treatment. Frank Dolan July 2, 2024
FDA Greenlights Shorla Oncology’s Tepylute, a Premix Formulation for Breast and Ovarian Cancer Treatment. Frank Dolan July 1, 2024
CDC’s Advisory Panel Endorses Vaxelis With Full Agreement to Protect Against Invasive Hemophilus Influenzae Type B Among Native American and Alaska Native Infants Frank Dolan June 28, 2024
FDA Sends Comprehensive Response Letter to Merck and Daiichi Sankyo Regarding Patritumab Deruxtecan for Advanced, Metastatic EGFR-Mutated Non-Small Cell Lung Cancer. Frank Dolan June 27, 2024
Novo Nordisk Commits $4.1 Billion to Enhance Production Facilities in the US Frank Dolan June 25, 2024
FDA Gives Green Light to Wakix by Harmony Biosciences for Treating Overwhelming Daytime Sleepiness in Children with Narcolepsy Frank Dolan June 24, 2024
NeuroBo’s DA-1726 Outperforms Survodutide in Weight Loss and Lipid-Lowering Pre-Clinical Models Arsenal June 24, 2024
